KIR3DL3/IL-2 Luciferase Reporter Jurkat Cell Line

Catalog #
78322
$11,250 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant Jurkat cell line expressing firefly luciferase under the control of an IL-2-responsive promoter, and with constitutive expression of human KIR3DL3 (Killer Cell Immunoglobulin Like Receptor, Three Ig Domains and Long Cytoplasmic Tail 3; GenBank accession #BC143802.1 corresponding to KIR3DL3*00402 allele).

Interested in screening and profiling inhibitors, blocking antibodies, or activators of KIR3DL3 without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
Killer cell immunoglobulin-like receptor 3DL3, CD158 antigen-like family member Z, Killer cell inhibitory receptor 1, CD_antigen: CD158z, CD158Z, KIR3DL7, KIRC1
Product Info
Storage and Usage
Citations
Host Cell Line
Jurkat cells (clone E6-1), Human T lymphoblast, suspension
Species
Human
Supplied As
Each vial contains >2 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience, #79796)
Materials Required But Not Supplied

Materials Required for Cell Culture 

Name Ordering Information
Thaw Medium 2 BPS Bioscience #60184
Growth Medium 2P BPS Bioscience #78354

 

Materials Required for Cellular Assay

Name Ordering Information
Anti-HHLA2(B7-H7) antibody1 Bahatt, RS, et al., 2021 (see references)
Growth Medium 2P BPS Bioscience #78354
Assay Medium: Thaw Medium 2 BPS Bioscience #60184
B7-H7(HHLA2)/TCR Activator CHO Cell Line BPS Bioscience #78321
Anti-CD28 agonist antibody BPS Bioscience #100186
96-well tissue culture treated, white clear-bottom assay plate Corning #3610
ONE-Step™ luciferase assay system BPS Bioscience #60690
Luminometer  
UniProt #
Q8N743, P60568
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

HHLA2 (B7-H7) mediates an immune-stimulatory signal via TMIGD2 (Transmembrane and immunoglobulin domain containing 2; CD28H) in naïve T cells while it delivers an immune-inhibitory signal through KIR3DL3 in activated T cells and Natural Killer (NK) cells. 

References

1. Bahatt RS, et. al., Cancer Immunol Res. 2021 Feb;9(2):156-169.